 0 Table of Contents |
  1 AdverseEvents for Clinical Research Home Page |
  2 Background and Workflow |
  3 Real World examples |
   3.1 Cancer Clinical Trial Example |
  4 Security Note |
  5 Useful Downloads |
  6 IG Change History |
  7 Artifacts Summary |
   7.1 Adverse Event Clinical Research |
   7.2 Adverse Event Grade |
   7.3 Adverse event caused subject to discontinue the study |
   7.4 Contributing Factor |
   7.5 Expected In Research Study |
   7.6 Mitigating Action |
   7.7 Note |
   7.8 Participant |
   7.9 Research Subject record of subject |
   7.10 Adverse Event resolution date |
   7.11 Resulting Effect |
   7.12 Criteria reviewed in determining serious adverse event |
   7.13 Workflow Status |
   7.14 Supporting information relevant to the event |
   7.15 Suspect Entity |
   7.16 AdverseEvent Contributing Factor |
   7.17 AdverseEvent Mitigating Action |
   7.18 Adverse Event Participant Functions |
   7.19 AdverseEvent Seriousness Non-serious Codes Only |
   7.20 Adverse Event Status |
   7.21 AdverseEvent Supporting Information |
   7.22 AdverseEvent Type |
   7.23 ClinicalTrialSignificantAdverseEvent |
   7.24 Patient reported AE during research study |
   7.25 adverse-event-compass-ex1 |
   7.26 adverse-event-compass-ex1a |
   7.27 adverse-event-compass-ex1b |
   7.28 adverse-event-compass-ex2 |
   7.29 AdverseEventFromProcedureNotStudyDrug |
   7.30 SeriousAdverseEventResearchStudy |
   7.31 NonSeriousAdverseEventResearchStudyMed |
   7.32 adverse-event-device-death |
   7.33 Serious Adverse Event |
   7.34 ClinicalTrialSubject5 |
   7.35 AEHepaticFailure |
   7.36 AEHepaticFailurecomplication |
   7.37 Janet Patient |
   7.38 Breast Cancer Trial |
   7.39 Janet weight Observation |
   7.40 Janet Blood Pressure Observation |
   7.41 Janet Tylenol PM med |
   7.42 Janet allergy med |
   7.43 Janet pill for water retention med not known |
   7.44 Medication Administration for bresentrik |
   7.45 Medication is bresentrik |
   7.46 Medication Request for bresentrik |
   7.47 Medication Administration of Med0301 |
   7.48 Medication Request for discontinued clinical trial medication ABC |
   7.49 Medication Request for discontinued clinical trial medication 0301 |
   7.50 Problem |
   7.51 patient-example-kaitlyn-b |
   7.52 practitioner-oncology-nurse-jane |
   7.53 practitioner-owen-oncologist |
   7.54 medication-request-example-kadcyla |
   7.55 medication-request-example-tucatinib |
   7.56 medication-administration-kadcyla |
   7.57 medication-administration-tucatinib |
   7.58 clinical-trial-example-compass |
   7.59 clinical-trial-example-subject |
   7.60 medication-administration-kadcyla-reduced |
   7.61 medication-administration-tucatinib-reduced |
   7.62 medication-request-example-zofran |
   7.63 GIBleed |
   7.64 research-study-XYZ |
   7.65 study-medication-ABC |
   7.66 study-medication-administration-ABC |
   7.67 procedure-upper-endoscopy |
   7.68 research-study-DISNEY |
   7.69 study-medication-MMD |
   7.70 study-medication-administration-MMD |
   7.71 medication-tylenol |
   7.72 medication-administration-tylenol |
   7.73 research-study-acme |
   7.74 clinical-trial-acme-subject |
   7.75 clinical-trial-acme-procedure |
   7.76 study-medication-administration-WBY |
   7.77 medication-contrast-dye |
   7.78 medication-administration-contrast-dye |
   7.79 medication-forhives |
   7.80 medication-administration-forhives |
   7.81 AEModeratehives |
   7.82 resstudy-medication-WBY |
   7.83 Patient MOUMIC |
   7.84 AEHeadache |
   7.85 Example patient SLP |
   7.86 Device - Infuser that exploded |
   7.87 clinical-trial-example-subject1 |
   7.88 medication-administration-kadcyla1 |
   7.89 medication-request-example-kadcyla1 |
   7.90 patient-example-kaitlyn-b1 |